These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8988868)

  • 1. Immunobiology of pseudorabies (Aujeszky's disease).
    Mettenleiter TC
    Vet Immunol Immunopathol; 1996 Nov; 54(1-4):221-9. PubMed ID: 8988868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes.
    Zuckermann FA; Zsak L; Mettenleiter TC; Ben-Porat T
    J Virol; 1990 Feb; 64(2):802-12. PubMed ID: 2153244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs.
    Gerdts V; Jöns A; Mettenleiter TC
    Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of the porcine cellular and humoral immune responses in vivo against pseudorabies virus after inoculation and challenge: significance of in vitro antigenic restimulation.
    De Bruin MG; De Visser YE; Kimman TG; Bianchi AT
    Vet Immunol Immunopathol; 1998 Sep; 65(1):75-87. PubMed ID: 9802578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine.
    Asai T; Tajima M; Watanabe H; Shibata I
    J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence.
    Gerdts V; Beyer J; Lomniczi B; Mettenleiter TC
    J Virol; 2000 Jan; 74(2):817-27. PubMed ID: 10623744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against pseudorabies virus (PrV).
    Freuling CM; Müller TF; Mettenleiter TC
    Vet Microbiol; 2017 Jul; 206():3-9. PubMed ID: 27890448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the development of vaccines against Aujeszky's disease].
    Mettenleiter TC
    Tierarztl Prax; 1995 Dec; 23(6):570-4. PubMed ID: 8585074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local humoral and cellular responses in Aujeszky's disease virus infection in pigs.
    Martin S; Wardley RC
    Res Vet Sci; 1987 Mar; 42(2):170-4. PubMed ID: 3035662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection.
    van Rooij EM; Haagmans BL; Glansbeek HL; de Visser YE; de Bruin MG; Boersma W; Bianchi AT
    Vet Immunol Immunopathol; 2000 Apr; 74(1-2):121-36. PubMed ID: 10760394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the Pseudorabies Virus gB Glycoprotein Triggers NK Cell Cytotoxicity and Increases Binding of the Activating NK Cell Receptor PILRβ.
    De Pelsmaeker S; Dierick E; Klupp B; Mettenleiter TC; Cantoni C; Vitale M; Favoreel HW
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
    Cook DR; Hill HT; Kinker DR
    Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.
    Somasundaram C; Takamatsu H; Andréoni C; Audonnet JC; Fischer L; Lefèvre F; Charley B
    Vet Immunol Immunopathol; 1999 Sep; 70(3-4):277-87. PubMed ID: 10507367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudorabies (Aujeszky's disease) virus: state of the art. August 1993.
    Mettenleiter TC
    Acta Vet Hung; 1994; 42(2-3):153-77. PubMed ID: 7810409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of maternally acquired Aujeszky's disease (pseudorabies) virus-specific antibody in pigs on establishment of latency and seroconversion to differential glycoproteins after low dose challenge.
    McCaw MB; Osorio FA; Wheeler J; Xu J; Erickson GA
    Vet Microbiol; 1997 Apr; 55(1-4):91-8. PubMed ID: 9220600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection.
    Zhang T; Liu Y; Chen Y; Wang A; Feng H; Wei Q; Zhou E; Zhang G
    Vaccine; 2020 Sep; 38(39):6153-6161. PubMed ID: 32741670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs.
    van Rooij EM; Rijsewijk FA; Moonen-Leusen HW; Bianchi AT; Rziha HJ
    Vaccine; 2010 Feb; 28(7):1808-13. PubMed ID: 20018271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH; Guo X; Ge XN; Jia H; Yang HC
    Acta Virol; 2007; 51(3):163-70. PubMed ID: 18076306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.